{"id":"self-injectable-epinephrine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Palpitations"},{"rate":"10-20%","effect":"Nervousness"},{"rate":"5-10%","effect":"Tremors"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"2-5%","effect":"Vomiting"},{"rate":"2-5%","effect":"Diarrhea"},{"rate":"2-5%","effect":"Abdominal pain"},{"rate":"2-5%","effect":"Muscle weakness"}]},"_chembl":{"chemblId":"CHEMBL1256958","moleculeType":"Small molecule","molecularWeight":"333.29"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Epinephrine is a medication that mimics the body's natural response to anaphylaxis, causing blood vessels to constrict, heart rate to increase, and bronchial tubes to dilate. This helps to alleviate symptoms such as difficulty breathing, rapid heartbeat, and a drop in blood pressure.","oneSentence":"Self-injectable epinephrine works by stimulating the body's natural response to anaphylaxis through the release of epinephrine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:33:49.293Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaphylaxis treatment"}]},"trialDetails":[{"nctId":"NCT05663320","phase":"NA","title":"A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia","status":"WITHDRAWN","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2025-12-09","conditions":"Congenital Adrenal Hyperplasia","enrollment":""},{"nctId":"NCT03779711","phase":"PHASE2","title":"Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Timothy J Nelson, MD, PhD","startDate":"2019-06-06","conditions":"Hypoplastic Left Heart Syndrome","enrollment":95},{"nctId":"NCT05443009","phase":"PHASE4","title":"Self-Reported Pain in Children Submitted to Single Infiltration of Articaine During Primary Molar Extraction","status":"COMPLETED","sponsor":"Universidade Federal de Santa Catarina","startDate":"2022-06-30","conditions":"Dental Pain, Anesthesia, Local","enrollment":76},{"nctId":"NCT05841290","phase":"NA","title":"The Incidence of Postoperative Pain After Using Different Types of Sealers","status":"RECRUITING","sponsor":"British University In Egypt","startDate":"2022-08-01","conditions":"Post Operative Pain, Root Canal Sealers, Sillicon Based Sealers","enrollment":50},{"nctId":"NCT06478615","phase":"NA","title":"Coring Out Fistulectomy With Closure of Internal Sphincter Opening Versus Lay Open Fistulotomy and Primary Sphincter Repair in Transsphincteric Perianal Fistula","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-11-30","conditions":"Coring Out, Fistulectomy, Internal Sphincter","enrollment":60},{"nctId":"NCT06456099","phase":"NA","title":"Feasibility of a Home Exercise Program With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain","status":"RECRUITING","sponsor":"Aalborg University","startDate":"2024-06-07","conditions":"Greater Trochanteric Pain Syndrome","enrollment":20},{"nctId":"NCT04865848","phase":"NA","title":"Comparison of Articaine Mandibular Infiltration to Lidocaine Inferior Alveolar Nerve Block in Pediatric Patients","status":"TERMINATED","sponsor":"University of Illinois at Chicago","startDate":"2019-06-05","conditions":"Anesthesia","enrollment":42},{"nctId":"NCT04760314","phase":"PHASE3","title":"A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2021-03-10","conditions":"Dermatitis, Atopic, Dermatitis, Eczema","enrollment":286},{"nctId":"NCT03727776","phase":"EARLY_PHASE1","title":"Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2019-08-19","conditions":"Proliferative Vitreoretinopathy","enrollment":11},{"nctId":"NCT01835964","phase":"NA","title":"Biobehavioral Mechanisms of Glucose Variability","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2013-04","conditions":"Diabetes Mellitus, Type 1","enrollment":30},{"nctId":"NCT02108496","phase":"NA","title":"Verifying the Effectiveness of the NUsurface® System","status":"COMPLETED","sponsor":"Active Implants","startDate":"2014-07","conditions":"Meniscectomy, Osteoarthritis","enrollment":127},{"nctId":"NCT02136901","phase":"NA","title":"The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System)","status":"COMPLETED","sponsor":"Active Implants","startDate":"2014-06","conditions":"Meniscectomy, Osteoarthritis","enrollment":34},{"nctId":"NCT04827784","phase":"NA","title":"Auriculotemporal Nerve Block in TMJ Disorders","status":"COMPLETED","sponsor":"Tokat Gaziosmanpasa University","startDate":"2020-01-15","conditions":"Temporomandibular Joint Disorders, Arthralgia of TMJ","enrollment":22},{"nctId":"NCT04207840","phase":"PHASE4","title":"Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2019-12-09","conditions":"Pharmacokinetics, Epinephrine, Albuterol","enrollment":28},{"nctId":"NCT04733781","phase":"PHASE2, PHASE3","title":"Subcutaneous Injection of Large Volumes of Tumescent Lidocaine and Epinephrine by Laypersons","status":"UNKNOWN","sponsor":"Jeffrey Alan Klein, MD","startDate":"2021-02-22","conditions":"Venomous Snakebites, Local Anesthesia, Painless Injection","enrollment":36},{"nctId":"NCT02478398","phase":"PHASE3","title":"Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1025},{"nctId":"NCT03399383","phase":"NA","title":"Adherence in Chronic Adrenal Insufficiency","status":"UNKNOWN","sponsor":"Wuerzburg University Hospital","startDate":"2016-09","conditions":"Adrenal Insufficiency","enrollment":150},{"nctId":"NCT01700192","phase":"PHASE3","title":"Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2013-01","conditions":"Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal","enrollment":1482},{"nctId":"NCT02256553","phase":"PHASE4","title":"Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2014-10","conditions":"Rhinitis, Allergic, Seasonal","enrollment":102},{"nctId":"NCT02417493","phase":"NA","title":"Self-injection and Self-management","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2015-03","conditions":"Food Allergy","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":117,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["EpiPen"],"phase":"phase_3","status":"active","brandName":"Self-injectable epinephrine","genericName":"Self-injectable epinephrine","companyName":"Merck Sharp & Dohme LLC","companyId":"merck-sharp-dohme-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Self-injectable epinephrine works by stimulating the body's natural response to anaphylaxis through the release of epinephrine. Used for Anaphylaxis treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}